Jiangsu Jibeier Pharmaceutical (SH:688566) Xin Lang Cai Jing·2025-10-13 03:58Group 1 - The core point of the news is that Jibeier's stock price has dropped by 5.07%, currently trading at 32.77 CNY per share, with a total market capitalization of 6.535 billion CNY [1] - Jibeier Pharmaceutical Co., Ltd. is located in Zhenjiang, Jiangsu Province, established on November 13, 2001, and listed on May 18, 2020. The company specializes in drug research, production, and sales [1] - The main revenue composition of Jibeier includes: Likujun tablets (72.72%), Niqunlol tablets (14.20%), Yupingfeng capsules (4.88%), others (4.53%), and Acetylsalicylic acid enteric-coated tablets (3.67%) [1] Group 2 - From the perspective of major fund holdings, one fund under GF Fund has a significant position in Jibeier. The fund, GF Stable Growth Mixed A (002622), held 10,500 shares in the second quarter, accounting for 0.51% of the fund's net value, ranking as the third-largest holding [2] - The current scale of GF Stable Growth Mixed A is 55.5805 million CNY, with a year-to-date return of 4.44%, ranking 6997 out of 8234 in its category [2] - The fund manager of GF Stable Growth Mixed A is Qiu Shilei, who has been in the position for 9 years and 261 days, with the best fund return during his tenure being 64.45% [3]